To develop a positron emission tomography/computed tomography (PET/CT)-based radiomics model for predicting programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients and estimating progression-free survival (PFS) and overall survival (OS) in PD-L1-positive patients undergoing first-line immunotherapy. We retrospectively analysed 143 NSCLC patients who underwent pretreatment ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) PET/CT scans, of whom 86 were PD-L1-positive. Clinical data collected included gender, age, smoking history, Tumor-Node-Metastases (TNM) staging system, pathologic types, laboratory parameters, and PET metabolic parameters. Four machine learning algorithms-Bayes, logistic, random forest, and Supportsupport vector machine (SVM)-were used to build models. The predictive performance was validated using receiver operating characteristic (ROC) curves. Univariate and multivariate Cox analyses identified independent predictors of OS and PFS in PD-L1-positive expression patients undergoing immunotherapy, and a nomogram was created to predict OS. A total of 20 models were built for predicting PD-L1 expression. The clinical combined PET/CT radiomics model based on the SVM algorithm performed best (area under curve for training and test sets: 0.914 and 0.877, respectively). The Cox analyses showed that smoking history independently predicted PFS. SUVmean, monocyte percentage and white blood cell count were independent predictors of OS, and the nomogram was created to predict 1-year, 2-year, and 3-year OS based on these three factors. We developed PET/CT-based machine learning models to help predict PD-L1 expression in NSCLC patients and identified independent predictors of PFS and OS in PD-L1-positive patients receiving immunotherapy, thereby aiding precision treatment.

Embolic protection devices (EPDs) used during carotid artery stenting (CAS) are crucial in reducing ischemic complications. Although minimizing the filter-type EPD movement is considered important, limited research has demonstrated this practice. We used an artificial intelligence (AI)-based device recognition technology to investigate the correlation between filter movements and ischemic complications. We retrospectively studied 28 consecutive patients who underwent CAS using FilterWire EZ (Boston Scientific, Marlborough, MA, USA) from April 2022 to September 2023. Clinical data, procedural videos, and postoperative magnetic resonance imaging were collected. An AI-based device detection function in the Neuro-Vascular Assist (iMed Technologies, Tokyo, Japan) was used to quantify the filter movement. Multivariate proportional odds model analysis was performed to explore the correlations between postoperative diffusion-weighted imaging (DWI) hyperintense lesions and potential ischemic risk factors, including filter movement. In total, 23 patients had sufficient information and were eligible for quantitative analysis. Fourteen patients (60.9 %) showed postoperative DWI hyperintense lesions. Multivariate analysis revealed significant associations between filter movement distance (odds ratio, 1.01; 95 % confidence interval, 1.00-1.02; p = 0.003) and high-intensity signals in time-of-flight magnetic resonance angiography with DWI hyperintense lesions. Age, symptomatic status, and operative time were not significantly correlated. Increased filter movement during CAS was correlated with a higher incidence of postoperative DWI hyperintense lesions. AI-based quantitative evaluation of endovascular techniques may enable demonstration of previously unproven recommendations. To the best of our knowledge, this is the first study to use an AI system for quantitative evaluation to address real-world clinical issues.

It is a challenging task to use ultrasound for bone imaging, as the bone tissue has a complex structure with high acoustic impedance and speed-of-sound (SOS). Recently, full waveform inversion (FWI) has shown promising imaging for musculoskeletal tissues. However, the FWI showed a limited ability and tended to produce artifacts in bone imaging because the inversion process would be more easily trapped in local minimum for bone tissue with a large discrepancy in SOS distribution between bony and soft tissues. In addition, the application of FWI required a high computational burden and relatively long iterations. The objective of this study was to achieve high-resolution ultrasonic imaging of bone using a deep learning-based FWI approach. In this paper, we proposed a novel network named CEDD-Unet. The CEDD-Unet adopts a Dual-Decoder architecture, with the first decoder tasked with reconstructing the SOS model, and the second decoder tasked with finding the main boundaries between bony and soft tissues. To effectively capture multi-scale spatial-temporal features from ultrasound radio frequency (RF) signals, we integrated a Convolutional LSTM (ConvLSTM) module. Additionally, an Efficient Multi-scale Attention (EMA) module was incorporated into the encoder to enhance feature representation and improve reconstruction accuracy. Using the ultrasonic imaging modality with a ring array transducer, the performance of CEDD-Unet was tested on the SOS model datasets from human bones (noted as Dataset1) and mouse bones (noted as Dataset2), and compared with three classic reconstruction architectures (Unet, Unet++, and Att-Unet), four state-of-the-art architecture (InversionNet, DD-Net, UPFWI, and DEFE-Unet). Experiments showed that CEDD-Unet outperforms all competing methods, achieving the lowest MAE of 23.30 on Dataset1 and 25.29 on Dataset2, the highest SSIM of 0.9702 on Dataset1 and 0.9550 on Dataset2, and the highest PSNR of 30.60 dB on Dataset1 and 32.87 dB on Dataset2. Our method demonstrated superior reconstruction quality, with clearer bone boundaries, reduced artifacts, and improved consistency with ground truth. Moreover, CEDD-Unet surpasses traditional FWI by producing sharper skeletal SOS reconstructions, reducing computational cost, and eliminating the reliance for an initial model. Ablation studies further confirm the effectiveness of each network component. The results suggest that CEDD-Unet is a promising deep learning-based FWI method for high-resolution bone imaging, with the potential to reconstruct accurate and sharp-edged skeletal SOS models.

Quality control (QC) of structures segmentation in volumetric medical images is important for identifying segmentation errors in clinical practice and for facilitating model development by enhancing network performance in semi-supervised and active learning scenarios. This paper introduces SegQC, a novel framework for segmentation quality estimation and segmentation error detection. SegQC computes an estimate measure of the quality of a segmentation in volumetric scans and in their individual slices and identifies possible segmentation error regions within a slice. The key components of SegQC include: 1) SegQCNet, a deep network that inputs a scan and its segmentation mask and outputs segmentation error probabilities for each voxel in the scan; 2) three new segmentation quality metrics computed from the segmentation error probabilities; 3) a new method for detecting possible segmentation errors in scan slices computed from the segmentation error probabilities. We introduce a novel evaluation scheme to measure segmentation error discrepancies based on an expert radiologist's corrections of automatically produced segmentations that yields smaller observer variability and is closer to actual segmentation errors. We demonstrate SegQC on three fetal structures in 198 fetal MRI scans - fetal brain, fetal body and the placenta. To assess the benefits of SegQC, we compare it to the unsupervised Test Time Augmentation (TTA)-based QC and to supervised autoencoder (AE)-based QC. Our studies indicate that SegQC outperforms TTA-based quality estimation for whole scans and individual slices in terms of Pearson correlation and MAE for fetal body and fetal brain structures segmentation as well as for volumetric overlap metrics estimation of the placenta structure. Compared to both unsupervised TTA and supervised AE methods, SegQC achieves lower MAE for both 3D and 2D Dice estimates and higher Pearson correlation for volumetric Dice. Our segmentation error detection method achieved recall and precision rates of 0.77 and 0.48 for fetal body, and 0.74 and 0.55 for fetal brain segmentation error detection, respectively. Ranking derived from metrics estimation surpasses rankings based on entropy and sum for TTA and SegQCNet estimations, respectively. SegQC provides high-quality metrics estimation for both 2D and 3D medical images as well as error localization within slices, offering important improvements to segmentation QC.

Accurate segmentation of cerebral arteries on computed tomography angiography (CTA) images is essential for the diagnosis and management of cerebrovascular diseases, including ischemic stroke. This study implemented a deep learning-based U-Net++ model for cerebral artery segmentation in CTA images, focusing on optimizing pruning levels by analyzing the trade-off between segmentation performance and computational cost. Dual-energy CTA and direct subtraction CTA datasets were utilized to segment the internal carotid and vertebral arteries in close proximity to the bone. We implemented four pruning levels (L1-L4) in the U-Net++ model and evaluated the segmentation performance using accuracy, intersection over union, F1-score, boundary F1-score, and Hausdorff distance. Statistical analyses were conducted to assess the significance of segmentation performance differences across pruning levels. In addition, we measured training and inference times to evaluate the trade-off between segmentation performance and computational efficiency. Applying deep supervision improved segmentation performance across all factors. While the L4 pruning level achieved the highest segmentation performance, L3 significantly reduced training and inference times (by an average of 51.56 % and 22.62 %, respectively), while incurring only a small decrease in segmentation performance (7.08 %) compared to L4. These results suggest that L3 achieves an optimal balance between performance and computational cost. This study demonstrates that pruning levels in U-Net++ models can be optimized to reduce computational cost while maintaining effective segmentation performance. By simplifying deep learning models, this approach can improve the efficiency of cerebrovascular segmentation, contributing to faster and more accurate diagnoses in clinical settings.

Confounding factors inherent in medical images can significantly impact the causal exploration capabilities of deep learning models, resulting in compromised accuracy and diminished generalization performance. In this paper, we present an innovative methodology named CausalMixNet that employs query-mixed intra-attention and key&value-mixed inter-attention to probe causal relationships between input images and labels. For mitigating unobservable confounding factors, CausalMixNet integrates the non-local reasoning module (NLRM) and the key&value-mixed inter-attention (KVMIA) to conduct a front-door adjustment strategy. Furthermore, CausalMixNet incorporates a patch-masked ranking module (PMRM) and query-mixed intra-attention (QMIA) to enhance mediator learning, thereby facilitating causal intervention. The patch mixing mechanism applied to query/(key&value) features within QMIA and KVMIA specifically targets lesion-related feature enhancement and the inference of average causal effect inference. CausalMixNet consistently outperforms existing methods, achieving superior accuracy and F1-scores across in-domain and out-of-domain scenarios on multiple datasets, with an average improvement of 3% over the closest competitor. Demonstrating robustness against noise, gender bias, and attribute bias, CausalMixNet excels in handling unobservable confounders, maintaining stable performance even in challenging conditions.

Clinical data warehouses, which have arisen over the last decade, bring together the medical data of millions of patients and offer the potential to train and validate machine learning models in real-world scenarios. The quality of MRIs collected in clinical data warehouses differs significantly from that generally observed in research datasets, reflecting the variability inherent to clinical practice. Consequently, the use of clinical data requires the implementation of robust quality control tools. By using a substantial number of pre-existing manually labelled T1-weighted MR images (5,500) alongside a smaller set of newly labelled FLAIR images (926), we present a novel semi-supervised adversarial domain adaptation architecture designed to exploit shared representations between MRI sequences thanks to a shared feature extractor, while taking into account the specificities of the FLAIR thanks to a specific classification head for each sequence. This architecture thus consists of a common invariant feature extractor, a domain classifier and two classification heads specific to the source and target, all designed to effectively deal with potential class distribution shifts between the source and target data classes. The primary objectives of this paper were: (1) to identify images which are not proper 3D FLAIR brain MRIs; (2) to rate the overall image quality. For the first objective, our approach demonstrated excellent results, with a balanced accuracy of 89%, comparable to that of human raters. For the second objective, our approach achieved good performance, although lower than that of human raters. Nevertheless, the automatic approach accurately identified bad quality images (balanced accuracy >79%). In conclusion, our proposed approach overcomes the initial barrier of heterogeneous image quality in clinical data warehouses, thereby facilitating the development of new research using clinical routine 3D FLAIR brain images.

This study aimed to develop and evaluate a non-invasive XGBoost-based machine learning model using radiomic features extracted from pre-treatment CT images to differentiate grade 4 renal cell carcinoma (RCC) from lower-grade tumours. A total of 102 RCC patients who underwent contrast-enhanced CT scans were included in the analysis. Radiomic features were extracted, and a two-step feature selection methodology was applied to identify the most relevant features for classification. The XGBoost model demonstrated high performance in both training (AUC = 0.87) and testing (AUC = 0.92) sets, with no significant difference between the two (p = 0.521). The model also exhibited high sensitivity, specificity, positive predictive value, and negative predictive value. The selected radiomic features captured both the distribution of intensity values and spatial relationships, which may provide valuable insights for personalized treatment decision-making. Our findings suggest that the XGBoost model has the potential to be integrated into clinical workflows to facilitate personalized adjuvant immunotherapy decision-making, ultimately improving patient outcomes. Further research is needed to validate the model in larger, multicentre cohorts and explore the potential of combining radiomic features with other clinical and molecular data.

The reliance on computationally intensive U-Net and Transformer architectures significantly limits their accessibility in low-resource environments, creating a technological divide that hinders global healthcare equity, especially in medical diagnostics and treatment planning. This divide is most pronounced in low- and middle-income countries, primary care facilities, and conflict zones. We introduced MED-NCA, Neural Cellular Automata (NCA) based segmentation models characterized by their low parameter count, robust performance, and inherent quality control mechanisms. These features drastically lower the barriers to high-quality medical image analysis in resource-constrained settings, allowing the models to run efficiently on hardware as minimal as a Raspberry Pi or a smartphone. Building upon the foundation laid by MED-NCA, this paper extends its validation across eight distinct anatomies, including the hippocampus and prostate (MRI, 3D), liver and spleen (CT, 3D), heart and lung (X-ray, 2D), breast tumor (Ultrasound, 2D), and skin lesion (Image, 2D). Our comprehensive evaluation demonstrates the broad applicability and effectiveness of MED-NCA in various medical imaging contexts, matching the performance of two magnitudes larger UNet models. Additionally, we introduce NCA-VIS, a visualization tool that gives insight into the inference process of MED-NCA and allows users to test its robustness by applying various artifacts. This combination of efficiency, broad applicability, and enhanced interpretability makes MED-NCA a transformative solution for medical image analysis, fostering greater global healthcare equity by making advanced diagnostics accessible in even the most resource-limited environments.